BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9530982)

  • 1. Transdermal delivery and accumulation of indomethacin in subcutaneous tissues in rats.
    Mikulak SA; Vangsness CT; Nimni ME
    J Pharm Pharmacol; 1998 Feb; 50(2):153-8. PubMed ID: 9530982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of erythromycin to subcutaneous tissues in rats by means of a trans-phase delivery system.
    Peng L; Nimni ME
    J Pharm Pharmacol; 1999 Oct; 51(10):1135-41. PubMed ID: 10579684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration.
    Miyazaki S; Takahashi A; Kubo W; Bachynsky J; Löebenberg R
    J Pharm Pharm Sci; 2003; 6(2):238-45. PubMed ID: 12935436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pulsed output ultrasound on the transdermal absorption of indomethacin from an ointment in rats.
    Asano J; Suisha F; Takada M; Kawasaki N; Miyazaki S
    Biol Pharm Bull; 1997 Mar; 20(3):288-91. PubMed ID: 9084890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of indomethacin by iontophoresis.
    Kanebako M; Inagi T; Takayama K
    Biol Pharm Bull; 2002 Jun; 25(6):779-82. PubMed ID: 12081146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled systemic delivery of indomethacin using membrane-moderated, cream formulation-based transdermal devices.
    Rao PR; Chalasani KB; Chauhan AS; Jain AK; Diwan PV; Ram MK
    Drug Deliv; 2006; 13(3):207-13. PubMed ID: 16556573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microemulsion: a novel transdermal delivery system to facilitate skin penetration of indomethacin.
    Chen L; Tan F; Wang J; Liu F
    Pharmazie; 2012 Apr; 67(4):319-23. PubMed ID: 22570938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transdermal microparticle delivery by a supersonic-Helios gun system].
    Jin Y; Uchida M; Wang CF; Natsume H; Sugibayashi K; Morimoto Y
    Yao Xue Xue Bao; 2001 Feb; 36(2):140-4. PubMed ID: 12579884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermally reversible xyloglucan gels as vehicles for oral drug delivery.
    Kawasaki N; Ohkura R; Miyazaki S; Uno Y; Sugimoto S; Attwood D
    Int J Pharm; 1999 Apr; 181(2):227-34. PubMed ID: 10370218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination with l-Menthol Enhances Transdermal Penetration of Indomethacin Solid Nanoparticles.
    Nagai N; Ogata F; Yamaguchi M; Fukuoka Y; Otake H; Nakazawa Y; Kawasaki N
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application.
    Singh P; Roberts MS
    J Pharmacol Exp Ther; 1994 Jan; 268(1):144-51. PubMed ID: 8301551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing effect of pyrrolidone derivatives on transdermal penetration of phenolsulfonphthalein and indomethacin from aqueous vehicle.
    Sasaki H; Kojima M; Nakamura J; Shibasaki J
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):797-9. PubMed ID: 2347025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal microparticle delivery by a supersonic-Helios gun system.
    Yi J; Chao W; Mashaki U; Hideshi N; Yasunori M
    Pharmazie; 2004 Dec; 59(12):934-6. PubMed ID: 15638081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local delivery of indomethacin to arthritis-bearing rats through polymeric micelles based on amphiphilic polyphosphazenes.
    Zhang JX; Yan MQ; Li XH; Qiu LY; Li XD; Li XJ; Jin Y; Zhu KJ
    Pharm Res; 2007 Oct; 24(10):1944-53. PubMed ID: 17530389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical therapies for rheumatoid arthritis by gel ointments containing indomethacin nanoparticles in adjuvant-induced arthritis rat.
    Nagai N; Yoshioka C; Ito Y
    J Oleo Sci; 2015; 64(3):337-46. PubMed ID: 25757439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs.
    Lee WR; Shen SC; Lai HH; Hu CH; Fang JY
    J Control Release; 2001 Jul; 75(1-2):155-66. PubMed ID: 11451505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
    Chauhan AS; Sridevi S; Chalasani KB; Jain AK; Jain SK; Jain NK; Diwan PV
    J Control Release; 2003 Jul; 90(3):335-43. PubMed ID: 12880700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue distribution and dermal drug determination of indomethacin transdermal-absorption patches.
    Ma J; Gao Y; Sun Y; Ding D; Zhang Q; Sun B; Wang M; Sun J; He Z
    Drug Deliv Transl Res; 2017 Oct; 7(5):617-624. PubMed ID: 28534130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin release in relation to the concentration of pharmaceutical excipients.
    Potúcková M; Vitková Z; Tichý E; Simunková V
    Pharmazie; 2008 Jun; 63(6):485-6. PubMed ID: 18604995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycaprolactone Based Nanoparticles Loaded with Indomethacin for Anti-Inflammatory Therapy: From Preparation to Ex Vivo Study.
    Badri W; Miladi K; Robin S; Viennet C; Nazari QA; Agusti G; Fessi H; Elaissari A
    Pharm Res; 2017 Sep; 34(9):1773-1783. PubMed ID: 28527126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.